SynthesisFrontiers in endocrinology2023

Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis.

Bing Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.